PlainRecalls
FDA Drug Low Class III Terminated

Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg, 3 Dispensers x 28 Tablets, Barr Laboratories, Inc., Pomona, NY NDC 0555-9051-67

Reported: July 23, 2014 Initiated: June 17, 2014 #D-1439-2014

Product Description

Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg, 3 Dispensers x 28 Tablets, Barr Laboratories, Inc., Pomona, NY NDC 0555-9051-67

Reason for Recall

Failed Impurities/Degradation Specifications: out of specification impurity test results.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
5265 blister packs
Distribution
Nationwide
Location
North Wales, PA

Frequently Asked Questions

What product was recalled?
Velivet (desogestrel and ethinyl estradiol tablets - triphasic regimen), 0.1 mg/0.025 mg; 0.125 mg/0.025 mg; 0.15 mg/0.025 mg, 3 Dispensers x 28 Tablets, Barr Laboratories, Inc., Pomona, NY NDC 0555-9051-67. Recalled by Teva Pharmaceuticals USA. Units affected: 5265 blister packs.
Why was this product recalled?
Failed Impurities/Degradation Specifications: out of specification impurity test results.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 23, 2014. Severity: Low. Recall number: D-1439-2014.